Tower Research Capital (TRC)’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,037
| Closed | -$225K | – | 7043 |
|
|
2022
Q1 | $225K | Buy |
8,037
+7,330
| +1,037% | +$201K | ﹤0.01% | 1641 |
|
|
2021
Q4 | $19K | Sell |
707
-770
| -52% | -$20.9K | ﹤0.01% | 3766 |
|
|
2021
Q3 | $40K | Sell |
1,477
-785
| -35% | -$19.4K | ﹤0.01% | 3141 |
|
|
2021
Q2 | $39K | Sell |
2,262
-1,661
| -42% | -$31.1K | ﹤0.01% | 3251 |
|
|
2021
Q1 | $82K | Buy |
3,923
+660
| +20% | +$15.2K | ﹤0.01% | 2746 |
|
|
2020
Q4 | $75K | Sell |
3,263
-31,816
| -91% | -$606K | ﹤0.01% | 2651 |
|
|
2020
Q3 | $572K | Buy |
35,079
+29,448
| +523% | +$533K | 0.01% | 1541 |
|
|
2020
Q2 | $76K | Buy |
5,631
+1,264
| +29% | +$14.7K | ﹤0.01% | 2706 |
|
|
2020
Q1 | $52K | Buy |
4,367
+4,366
| +436,600% | +$96.8K | ﹤0.01% | 1283 |
|
|
2019
Q4 | $0 | Sell |
1
-786
| -100% | -$15.9K | ﹤0.01% | 4692 |
|
|
2019
Q3 | $13K | Buy |
+787
| New | +$14.3K | ﹤0.01% | 2798 |
|
|
2019
Q2 | – | Sell |
-63
| Closed | -$2K | – | 4551 |
|
|
2019
Q1 | $2K | Buy |
63
+39
| +163% | +$1.21K | ﹤0.01% | 3491 |
|
|
2018
Q4 | $1K | Sell |
24
-1,242
| -98% | -$36.4K | ﹤0.01% | 3709 |
|
|
2018
Q3 | $36K | Buy |
+1,266
| New | +$38K | ﹤0.01% | 1972 |
|
|
2018
Q1 | – | Sell |
-1,304
| Closed | -$42K | – | 4063 |
|
|
2017
Q4 | $42K | Sell |
1,304
-379
| -23% | -$11.4K | 0.01% | 1469 |
|
|
2017
Q3 | $52K | Buy |
+1,683
| New | +$49.8K | ﹤0.01% | 1935 |
|
|
2016
Q3 | – | Sell |
-508
| Closed | -$7K | – | 4749 |
|
|
2016
Q2 | $7K | Sell |
508
-3,098
| -86% | -$48.5K | ﹤0.01% | 3183 |
|
|
2016
Q1 | $68K | Buy |
3,606
+3,193
| +773% | +$57.8K | 0.01% | 635 |
|
|
2015
Q4 | $9K | Sell |
413
-328
| -44% | -$6.49K | ﹤0.01% | 2321 |
|
|
2015
Q3 | $17K | Sell |
741
-416
| -36% | -$11.5K | ﹤0.01% | 1902 |
|
|
2015
Q2 | $33K | Buy |
1,157
+219
| +23% | +$5.74K | ﹤0.01% | 1694 |
|
|
2015
Q1 | $24K | Buy |
+938
| New | +$21.5K | ﹤0.01% | 2116 |
|
|
2014
Q4 | – | Sell |
-959
| Closed | -$15K | – | 4922 |
|
|
2014
Q3 | $15K | Buy |
+959
| New | +$14.4K | ﹤0.01% | 2554 |
|
Tower Research Capital (TRC)'s XENT Position: Q2 2022 in Review
Tower Research Capital (TRC) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 8,037 shares — an estimated $225K sold.
Tower Research Capital (TRC) first reported a position in XENT in Q3 2014 and held it in 23 quarters. The position peaked at $572K in Q3 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Tower Research Capital (TRC) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 8,037 Intersect ENT, Inc shares in Q2 2022, an estimated $225K.
- Tower Research Capital (TRC) first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 23 quarters.
- Tower Research Capital (TRC)'s Intersect ENT, Inc position peaked at $572K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.